Cargando…

Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach

BACKGROUND: The increasing amount of molecular data and knowledge about genomic alterations from next-generation sequencing processes together allow for a greater understanding of individual patients, thereby advancing precision medicine. Molecular tumour boards feature multidisciplinary teams of cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez Ruiz, Núria, Abd Own, Sulaf, Ekström Smedby, Karin, Eloranta, Sandra, Koch, Sabine, Wästerlid, Tove, Krstic, Aleksandra, Boman, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705761/ https://www.ncbi.nlm.nih.gov/pubmed/36457495 http://dx.doi.org/10.3389/fonc.2022.984021

Ejemplares similares

Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study
por: Wästerlid, Tove, et al.
Publicado: (2020)

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
por: Joelsson, Joel, et al.
Publicado: (2022)

Predictive models for clinical decision making: Deep dives in practical machine learning
por: Eloranta, Sandra, et al.
Publicado: (2022)

Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
por: Wästerlid, Tove, et al.
Publicado: (2021)

Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma
por: Hjerpe, Anders, et al.
Publicado: (2020)

Utility of BerEp4/calretinin and desmin/epithelial membrane antigen (EMA) dual immunocytochemical staining in effusion cytology
por: Hjerpe, Anders, et al.
Publicado: (2022)

Application of precision medicine in clinical routine in haematology—Challenges and opportunities
por: Wästerlid, Tove, et al.
Publicado: (2022)

Sex differences in lymphoma incidence and mortality by subtype: A population‐based study
por: Radkiewicz, Cecilia, et al.
Publicado: (2022)

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
por: Weibull, Caroline E., et al.
Publicado: (2023)

Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
por: Haider, Zahra, et al.
Publicado: (2023)

Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission
por: Ekberg, Sara, et al.
Publicado: (2022)

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
por: Frisk, Gabriella, et al.
Publicado: (2017)

Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c(+) Expression in Tumor
por: Magalhaes, Isabelle, et al.
Publicado: (2020)

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions
por: Hillerdal, Carl-Olof, et al.
Publicado: (2017)

The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study
por: Mohammadi, Mohammad, et al.
Publicado: (2015)

Concordance in survival among first‐degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
por: Baecklund, Fredrik, et al.
Publicado: (2020)

Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data
por: Syriopoulou, Elisavet, et al.
Publicado: (2022)

Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience
por: Sonnevi, Kristina, et al.
Publicado: (2021)

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
por: Harrysson, Sara, et al.
Publicado: (2021)

Family history of colorectal cancer and survival: a Swedish population‐based study
por: Pesola, F., et al.
Publicado: (2020)

Buses and Boards: Making the right choice
por: Gipper, Jerry
Publicado: (2009)

Simplicity at the cost of predictive accuracy in diffuse large B‐cell lymphoma: a critical assessment of the R‐IPI, IPI, and NCCN‐IPI
por: Biccler, Jorne, et al.
Publicado: (2017)

ChatGPT in glioma adjuvant therapy decision making: ready to assume the role of a doctor in the tumour board?
por: Haemmerli, Julien, et al.
Publicado: (2023)

No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study
por: Frisk, Gabriella, et al.
Publicado: (2018)

Decision making in global health: is everyone on board?
por: The Lancet Global Health
Publicado: (2022)

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
por: Azzollini, Jacopo, et al.
Publicado: (2022)

Enhancing the performance of gastrointestinal tumour board by improving documentation
por: Alsuhaibani, Roaa Saleh, et al.
Publicado: (2018)

Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients
por: Harrysson, Sara, et al.
Publicado: (2022)

Knowledge-driven board-level functional fault diagnosis
por: Ye, Fangming, et al.
Publicado: (2017)

Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
por: Baech, Joachim, et al.
Publicado: (2022)

Bayesian Framework to Augment Tumor Board Decision Making
por: Pasetto, Stefano, et al.
Publicado: (2021)

Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors—A population‐based cohort study from Sweden and Denmark
por: Glimelius, Ingrid, et al.
Publicado: (2019)

P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
por: Baech, Joachim, et al.
Publicado: (2022)

Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study
por: Ekström, Magnus, et al.
Publicado: (2014)

Patient attrition in Molecular Tumour Boards: a systematic review
por: Frost, Hannah, et al.
Publicado: (2022)

A multiscale model of epigenetic heterogeneity-driven cell fate decision-making
por: Folguera-Blasco, Núria, et al.
Publicado: (2019)

HBR's 10 must reads on boards (with bonus article 'what makes great boards great' by Jeffrey A. Sonnenfeld)
por: Sonnenfeld, Jeffrey A, et al.
Publicado: (2020)

Multidisciplinary approach to cancer care in Rwanda: the role of tumour board meetings
por: Niyibizi, Brandon A, et al.
Publicado: (2023)

Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine
por: Ballatore, Zelmira, et al.
Publicado: (2023)

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
por: Ludvigsson, Jonas F, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rplooiobftap96k84q5n3dlb3g